SPECIAL REPORT
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Existing-Home Sales Jump To Highest Level in 2-1/2 Years
- Paul: Audit the Fed
- Wave of Debt Payments Facing US Government
- TV Retailer QVC Joins 'Black Friday' Frenzy
- Start-Up Proves Everything Really Is Better With Bacon
- Buffett's Wealth and Fame Hasn't Helped 'Warren' As a Name
- Madoff—The Holiday Drink
- S&P Stocks Trading at New 52-Week Highs
- Nov. 23: Unusual Volume Leaders
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
- Rally Could 'Have Some Legs in 2010': Market Strategist
- Investors May Skew Housing Reality
- Buffett's Wealth and Fame Hasn't Helped 'Warren' As a Name
- Are Crazy Retail Deals Good for Business?
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- Wall Street 'Bonuses' Disappear—but Only in Name
- Why the Dollar Will Likely Stay Weak for Some Time
- Bear, Lehman Execs Weren't Wiped Out by Crisis: Study
- How Real Estate Investors Skew Housing's Reality
- Vioxx Showed Risk Signs Before Being Pulled: Report
- Even Buffett's Huge Fame Can't Help the Name 'Warren'
- Wave of Debt Payments Facing US Government
- JPMorgan's Dimon Could Succeed Geithner: Report
- Suze Orman’s 'A Healthier, Wealthier You'
PHARMA'S MARKET VIDEO
RSS FEED
Pharma's Market
![]() |
CNBC.com |
But for some reason last Friday evening — maybe because I was bored on the train ride home and I don't pass the time playing "Brickbreaker" — I opened and paged down one of the stock-stat emails.
It came as no surprise that General Motors is the December dog of the Dow — down more than 30 percent so far this month.
But I was definitely caught off guard when I saw that Merck (Merck!) is the best performing Dow component in December, with less than three trading days left. MRK shares [MRK
Loading...
()
] are up eight-and-a-half percent.
Could the drugmaker's annual analyst meeting earlier this month have been a catalyst? Or did investors simply decide the stock's cheap with a high dividend yield?
Check back later today when I will reveal the best-performing Nasdaq 100 stock year-to-date. The index is down 42 percent in 2008. But the top stock is up nearly 27 percent. Hint: It's a biopharma stock.
Questions? Comments?










